News

During a live event, Naresh Bumma, MD, discussed CRS, oral and skin toxicities, and low discontinuation rates with ...
Flatiron Health today announced 14 abstracts leveraging its high-quality real-world oncology data have been accepted for poster presentation and online publication at the 2025 American Society of ...
A nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma.
A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...
Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...
A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of ...
A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and ...
A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...
Multiple myeloma is a disease that most people haven’t heard of until it impacts their lives directly. This blood cancer can sound daunting but understanding it is the first step towards ...
Multiple myeloma represents an unmet need, emphasizing the significance of continued research and development in this field. Treatment with cemsidomide resulted in notable responses at multiple dose ...
I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and vitality.